| Cat.No. | Name | Information |
|---|---|---|
| M2206 | TH-302 (Evofosfamide) | TH-302 is a highly potent and selective hypoxia-activated procompound targeting hypoxic regions of solid tumors with IC50 of 19 nM. |
| M6098 | Baicalein | Baicalein is a CYP2C9 and prolyl endopeptidase inhibitor, IC50 value of 3.12 mM. |
| M9325 | EGTA | EGTA is a specific calcium chelator with a Kd of 60.5 nM at physiological pH (7.4) and a high specificity for Ca2+ than for Mg2+.EGTA significantly inhibits the substrate adhesion capacity of inflammatory macrophages. |
| M9330 | Brij-35 | Brij-35 (Polidocanol) is a high HLB, ethoxylated, nonionic ether of lauryl alcohol with broad pH stability. |
| M6154 | 2-PMPA tetrasodium | 2-PMPA (PMPA tetrasodium salt) is a potent and selective inhibitor of glutamate carboxypeptidase II (GCPII) with an IC50 of 300 pM. |
| M2250 | Pamidronate disodium | Pamidronate disodium is a nitrogen containing bisphosphonate, used to the research of preventing osteoporosis. |
| M9916 | DPPH | DPPH (2,2-Diphenyl-1-picrylhydrazyl) is a stable free radical that measures the free radical scavenging activity of antioxidants. |
| M9194 | Insulin (human) | Insulin (human) is a polypeptide hormone that regulates the level of sugar (glucose) in the blood and is produced by beta cells of islets. |
| M3409 | Formestane | Formestane is a second generation selective aromatase inhibitor with an IC50 of 80 nM. |
| M9665 | N-(2-amino-2-oxoethyl)acrylamide | N-(2-Amino-2-oxoethyl)acrylamide |
| M10946 | Glyco-Obeticholic acid | Glyco-obeticholic acid is an active metabolite of taurine. Obeticholic Acid is an oral bioavailable fancy-like X receptor (FXR) agonist. |
| M10944 | BT-13 | BT-13 is a potent, glial-derived neurotrophic factor (GDNF) receptor RET selective agonist (independent of GDNF ligands) that promotes the growth of process ninsters in vitro sensory neurons and mitigates the occurrence of neuropathy in rats. |
| M10912 | asukamycin | |
| M10911 | ZXH-3-26 | ZXH-3-26 is a PROTAC connected by the Cereblon ligand and brd4 ligands, and after 5 hours of processing,DC50 Approximately 5 nM. |
| M10901 | viloxazine | |
| M10895 | Umirolimus | Umirolimus, a derivative of macrotriene lactone Rapamycin, is a powerful immunosuppressant and anti-inflammatory agent. Umirolimus is highly lipophilic and can be used as a drug-eluting stent. |
| M10893 | Tesetaxel | |
| M10891 | Taranabant | Taranabant is a potent and selective cannabinoid 1 (CB1) receptor reverse agonist that inhibits binding and the functional activity of multiple agonists, acting on human CB1R,Ki 0.13 nM. |
| M10889 | SHP836 | SHP836 is an allosteric inhibitor of SHP2 that inhibits SHP2 IC50 The value is 12 μM. |
| M10888 | SHP394 | SHP394 is a potent, orally active, allosterical selective SHP2 inhibitor,IC50 23 nM. |
| M10887 | SHP389 | SHP389 is an allosteric inhibitor of SHP2, which is anti-SHP2 and p-ERK IC50 The values are all 36 nM. |
| M10882 | RMC-0331 | RMC-0331 (RM-023) is a highly potent, selective, and oral bioavailable SOS1 inhibitor. RMC-0331 is an in vivo tool compound that blocks RAS activation by disrupting RAS-SOS1 interactions. |
| M10878 | Reldesemtiv | Reldesemtiv (CK-2127107) is a selective, orally active next-generation rapid skeletal muscle troponin activator (FSTA). Reldesemtiv selectively activates rapid skeletal muscle fibrils, EC50Is 3.4 μM. |
| M10877 | QCA570 | QCA570 is made up of Cereblon ligands and BET ligands connected to PROTAC, which is paired with the BRD4 BD1 protein IC50 The value is 10 nM. |
| M10874 | plocabulin | Pm-060184 is a microtubulin polymerization inhibitor. |
| M10872 | Lufotrelvir | PF-07304814 IS A PHOSPHATE PRODRUG FOR PF-00835231 THAT BINDS AND INHIBITS SARS-CoV-2 3CLpro Active, Ki is 174 nM. |
| M10869 | OP-5244 | OP-5244 is a potent and orally active CD73 inhibitor,IC50 The value is 0.25 nM. OP-5244 reverses the immunosuppressive effect by blocking the production of adenosine, with the potential to conduct cancer research. |
| M10866 | NSC-70220 | NSC-70220 is a selective allosteric SOS1 inhibitor. NSC-70220 inhibits allosteric site activation and partially inhibits catalytic site activation. NSC-70220 has anti-cancer effects. |
| M10864 | Nicodicosapent | Nicodicosapent is a fatty acid niacin conjugate that inhibits the activity of sterol regulatory element binding proteins (SREBP) and the activity of proteins that regulate cholesterol metabolism such as PCSK9, HMG-CoA reductase, ATP citrate lyase, and NPC1L1. |
| M10863 | NCGC00378430 | NCGC00378430 is a potent inhibitor of the SIX1/EYA2 interaction. NCGC00378430 partially reverses SIX1 overexpression-mediated transcription and metabolic profiling, and reverses SIX1-induced TGF-β signaling and epithelial-interstitial transformation (EMT). NCGC00378430 inhibits SIX1-mediated breast cancer metastasis in mouse models. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
